Rosenke, K., Hansen, F., Schwarz, B., Feldmann, F., Haddock, E., Rosenke, R., . . . Jarvis, M. A. (2021). Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nature Portfolio.
Cita Chicago Style (17a ed.)Rosenke, Kyle, et al. Orally Delivered MK-4482 Inhibits SARS-CoV-2 Replication in the Syrian Hamster Model. Nature Portfolio, 2021.
Cita MLA (8a ed.)Rosenke, Kyle, et al. Orally Delivered MK-4482 Inhibits SARS-CoV-2 Replication in the Syrian Hamster Model. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.